Research / XYL / Fundamental state Inspectable configuration
State dimensions Filing 0001524472-25-000022 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
98.07% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.43% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
1.59% · OPTIONAL · VALID
Revenue growth 35th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
1.77% · CORE · VALID
Inventory pressure 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
49.40% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
37.12% · CORE · VALID
Operating margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
11.16% · CORE · VALID
R&D intensity 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.71% · OPTIONAL · VALID
SBC intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.58% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 49 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 8/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 23.72%
Current 98.07%
Delta 74.35% Capex Intensity Decreased
Previous 3.75%
Current 3.43%
Delta -0.32% Cash Generation Decreased
Previous 14.75%
Current 1.59%
Delta -13.16% Growth Decreased
Previous 16.27%
Current 1.77%
Delta -14.50% Inventory Pressure Increased
Previous 11.63%
Current 49.40%
Delta 37.76% Margin Decreased
Previous 37.51%
Current 37.12%
Delta -0.40% Profitability Decreased
Previous 11.78%
Current 11.16%
Delta -0.62% R And D Intensity Increased
Previous 2.69%
Current 2.71%
Delta 0.02% Sbc Intensity Decreased
Previous 0.65%
Current 0.58%
Delta -0.07% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.